A Phase 3 Double-Blind, Placebo-Controlled Study to assess the efficacy, safety and tolerability of NKTR-181 In Opioid-Naïve subjects with moderate to severe chronic low back pain.

  • STATUS
    Not Recruiting
  • sponsor
    Nektar
Updated on 21 April 2022

Summary

A Phase 3 Double-Blind, Placebo-Controlled Study to assess the efficacy, safety and tolerability of NKTR-181 In Opioid-Naïve subjects with moderate to severe chronic low back pain.

Description

This study is being conducted to evaluate the safety and effectiveness of a study drug for the treatment of chronic low back pain. If you qualify for participation in this study, your participation would last approximately 25 weeks and you would be required to make about 20 office visits to our clinic. As a qualified participant you will be compensated $50 per visit. Also, as a participant in the study you will receive study medication or placebo, physical exams, lab tests, and other medical tests as necessary for the completion of this study, at no cost to you.

Details
Condition Chronic Back Pain
Clinical Study IdentifierTX141212
SponsorNektar
Last Modified on21 April 2022

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note